TFF Pharmaceuticals Enters into CRADA with the U.S. Army and The Geneva Foundation to Develop Dry Powder Needle-free Medical Countermeasures
Originally published by: TFF Pharmaceuticals New collaboration to study the use of Thin Film Freezing technology to formulate dry powder recombinant vaccine against SARS-CoV-2 for pulmonary delivery AUSTIN, Texas, March 17, 2022 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin